ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination.
Journal
Case reports in nephrology
ISSN: 2090-6641
Titre abrégé: Case Rep Nephrol
Pays: United States
ID NLM: 101598418
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
12
2022
revised:
17
03
2023
accepted:
06
04
2023
medline:
27
4
2023
pubmed:
27
4
2023
entrez:
27
4
2023
Statut:
epublish
Résumé
We experienced a case of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis after Moderna COVID-19 vaccination. An 82-year-old woman developed pyrexia and general malaise one month after her third booster vaccine, and the symptoms persisted. Blood testing revealed inflammation, a high level of MPO-ANCA, and microscopic hematuria. MPO-ANCA-associated vasculitis was diagnosed by renal biopsy. The symptoms improved with steroid therapy. Common adverse reactions to mRNA vaccines against COVID-19 include pyrexia and general malaise, but MPO-ANCA-associated vasculitis can also occur. If pyrexia, prolonged general malaise, urinary occult blood, or renal impairment is observed, the onset of MPO-ANCA-associated vasculitis should be considered.
Identifiants
pubmed: 37101523
doi: 10.1155/2023/4906876
pmc: PMC10125765
doi:
Types de publication
Case Reports
Langues
eng
Pagination
4906876Informations de copyright
Copyright © 2023 Shiko Gen et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
Rheumatol Int. 2021 Aug;41(8):1523-1529
pubmed: 34100115
N Engl J Med. 2022 Mar 17;386(11):1046-1057
pubmed: 35081293
J Clin Rheumatol. 2008 Aug;14(4):243-4
pubmed: 18766128
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Med Sci Monit. 2020 May 05;26:e924700
pubmed: 32366816
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1680-1691
pubmed: 28842398
J Immunol Res. 2019 May 6;2019:1732175
pubmed: 31198793
Am J Kidney Dis. 2021 Oct;78(4):611-613
pubmed: 34280507
J Korean Med Sci. 2022 Jul 04;37(26):e204
pubmed: 35790206
Kidney Int. 2021 Aug;100(2):473-474
pubmed: 34081948
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129
pubmed: 33507892
Intern Med. 2005 Aug;44(8):892-6
pubmed: 16157995
Am J Nephrol. 2013;38(2):174-8
pubmed: 23941822
Lancet. 1993 Sep 11;342(8872):651-2
pubmed: 8103148
Rheumatol Int. 2022 Apr;42(4):749-758
pubmed: 35124725
Immunol Rev. 2016 Jan;269(1):60-75
pubmed: 26683145
Kidney Int Rep. 2021 Dec;6(12):2969-2978
pubmed: 34632166
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Clin Exp Nephrol. 2022 Apr;26(4):316-322
pubmed: 34773533
Kidney Int. 2021 Nov;100(5):959-965
pubmed: 34534551